Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

59.11USD
1:32am IST
Price Change (% chg)

$0.09 (+0.15%)
Prev Close
$59.02
Open
$59.21
Day's High
$59.34
Day's Low
$58.84
Volume
71,371
Avg. Vol
106,744
52-wk High
$62.49
52-wk Low
$44.12

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is a global provider of solutions, which accelerate the early-stage drug discovery and development process. The focus of its business is in vivo biology; its portfolio includes research models and services required to enable in vivo drug discovery and development. The Company... (more)

Overall

Beta: 0.96
Market Cap (Mil.): $2,754.88
Shares Outstanding (Mil.): 46.68
Dividend: --
Yield (%): --

Financials

Search Stocks

Charles River to buy Galapagos drug service operations

BRUSSELS, March 13 - Belgian biotechnology group Galapagos said on Thursday it had agreed to sell its drug discovery service businesses to Charles River Laboratories International for up to 134 million euros ($186.3 million).

13 Mar 2014

BRIEF-Galapagos says Charles River Labs to acquire co's argenta, biofocus service ops

BRUSSELS, March 13 - Galapagos NV : * Charles River Laboratories to acquire Galapagos' argenta and biofocus service operations for up to EUR134 million * Says earnout of EUR5 million upon achievement of revenue target after 12 months * Management guidance for 2014 group revenues of EUR125 million and year end cash of EUR170 million * Says proceeds to be used to progress galapagos' pipeline * Charles River agrees to pay Galapagos immediate cash consideration of EUR129 million * Sa

13 Mar 2014

Earnings vs. Estimates

Search Stocks